Cancer Aware · Patient & Family Guide

Evidence and Medical Review Status

Sources, evidence limitations and physician review status for the Endometrial Cancer Master Guide.

Educational information for patients and families. This guide supports, but does not replace, individualized medical advice. It cannot diagnose, stage cancer or prescribe treatment.

All 25 chapters

Authorship and review status

Medical Content & Review: Dr Hakeem Ansar Hussain, Medical Oncologist. Evidence and editorial checking for this addition was performed on 29–30 October 2026. Personal physician review of this version has not been recorded; no last medically reviewed date or individual physician approval is claimed.

Evidence scope

Sources include FIGO 2023, the 2025 ESGO–ESTRO–ESP update, ACOG 2026 bleeding guidance, NCI, FDA, EMA and primary clinical trials. Licensed NCCN and full ESMO professional guidance were not comprehensively accessed; this guide does not claim line-by-line verification against them. The WHO classification is referenced for terminology, not claimed to have been exhaustively reviewed.

How to interpret evidence

Trial populations, comparisons and endpoints differ. PFS is not overall survival; response is not cure. Exploratory molecular subgroups and conference updates are labelled accordingly. Regulatory approval in one country does not establish worldwide availability. Prior immunotherapy changes the relevance of older subsequent-line studies.

Review before medical approval

The clinician should confirm staging boundaries, molecular precedence and variants, 2026 bleeding evaluation, fertility selection, adjuvant risk groups, trial descriptions, regional labels, post-immunotherapy sequencing and every tool branch. Record the reviewed version, actual date, scope and corrections before changing medical-review status.

Educational limitations

These pages do not diagnose, prescribe or replace individualized multidisciplinary care. Tools do not collect identifying details or assign clinical stages. Serious symptoms require direct medical assessment.

References and review status

Evidence/editorial check: 30 October 2026. Individual physician review is not recorded. Local approvals, resources and clinical guidance must be confirmed by the treating team.

Evidence scope and update policy